nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP3A4—Ifosfamide—germ cell cancer	0.0424	0.352	CbGbCtD
Ranolazine—CYP2D6—Vinblastine—germ cell cancer	0.0354	0.294	CbGbCtD
Ranolazine—CYP3A4—Vinblastine—germ cell cancer	0.0225	0.187	CbGbCtD
Ranolazine—CYP3A4—Etoposide—germ cell cancer	0.0203	0.168	CbGbCtD
Ranolazine—Lethargy—Dactinomycin—germ cell cancer	0.00645	0.00733	CcSEcCtD
Ranolazine—Renal failure acute—Ifosfamide—germ cell cancer	0.00627	0.00713	CcSEcCtD
Ranolazine—Amnesia—Ifosfamide—germ cell cancer	0.00616	0.00701	CcSEcCtD
Ranolazine—Pain in extremity—Ifosfamide—germ cell cancer	0.00579	0.00658	CcSEcCtD
Ranolazine—Pancytopenia—Bleomycin—germ cell cancer	0.00556	0.00632	CcSEcCtD
Ranolazine—Hypoaesthesia—Vinblastine—germ cell cancer	0.00552	0.00628	CcSEcCtD
Ranolazine—Urinary retention—Ifosfamide—germ cell cancer	0.0055	0.00626	CcSEcCtD
Ranolazine—Blood creatinine increased—Ifosfamide—germ cell cancer	0.00542	0.00617	CcSEcCtD
Ranolazine—Renal failure acute—Cisplatin—germ cell cancer	0.00541	0.00615	CcSEcCtD
Ranolazine—Amnesia—Cisplatin—germ cell cancer	0.00531	0.00604	CcSEcCtD
Ranolazine—Weight decreased—Bleomycin—germ cell cancer	0.0053	0.00602	CcSEcCtD
Ranolazine—Breast disorder—Ifosfamide—germ cell cancer	0.00523	0.00595	CcSEcCtD
Ranolazine—Pancytopenia—Dactinomycin—germ cell cancer	0.00519	0.0059	CcSEcCtD
Ranolazine—Haematuria—Bleomycin—germ cell cancer	0.00498	0.00566	CcSEcCtD
Ranolazine—Pancreatitis—Ifosfamide—germ cell cancer	0.00491	0.00558	CcSEcCtD
Ranolazine—Pancytopenia—Ifosfamide—germ cell cancer	0.00475	0.0054	CcSEcCtD
Ranolazine—Dysuria—Ifosfamide—germ cell cancer	0.00468	0.00532	CcSEcCtD
Ranolazine—Blood creatinine increased—Cisplatin—germ cell cancer	0.00468	0.00532	CcSEcCtD
Ranolazine—Hypoaesthesia—Bleomycin—germ cell cancer	0.00466	0.0053	CcSEcCtD
Ranolazine—Dehydration—Cisplatin—germ cell cancer	0.00464	0.00528	CcSEcCtD
Ranolazine—Orthostatic hypotension—Cisplatin—germ cell cancer	0.00456	0.00518	CcSEcCtD
Ranolazine—Breast disorder—Cisplatin—germ cell cancer	0.00451	0.00513	CcSEcCtD
Ranolazine—Cramp muscle—Cisplatin—germ cell cancer	0.00449	0.00511	CcSEcCtD
Ranolazine—Renal failure—Ifosfamide—germ cell cancer	0.00439	0.00499	CcSEcCtD
Ranolazine—Vertigo—Vinblastine—germ cell cancer	0.00434	0.00493	CcSEcCtD
Ranolazine—Leukopenia—Vinblastine—germ cell cancer	0.00432	0.00492	CcSEcCtD
Ranolazine—Haematuria—Ifosfamide—germ cell cancer	0.00425	0.00484	CcSEcCtD
Ranolazine—Pancreatitis—Cisplatin—germ cell cancer	0.00423	0.00481	CcSEcCtD
Ranolazine—Abdominal discomfort—Cisplatin—germ cell cancer	0.00414	0.0047	CcSEcCtD
Ranolazine—Cramp muscle—Etoposide—germ cell cancer	0.00412	0.00468	CcSEcCtD
Ranolazine—Pancytopenia—Cisplatin—germ cell cancer	0.0041	0.00466	CcSEcCtD
Ranolazine—Bradycardia—Ifosfamide—germ cell cancer	0.00408	0.00464	CcSEcCtD
Ranolazine—Hallucination—Ifosfamide—germ cell cancer	0.00398	0.00453	CcSEcCtD
Ranolazine—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00396	0.0045	CcSEcCtD
Ranolazine—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00394	0.00447	CcSEcCtD
Ranolazine—Urethral disorder—Ifosfamide—germ cell cancer	0.00393	0.00446	CcSEcCtD
Ranolazine—Thrombocytopenia—Vinblastine—germ cell cancer	0.00386	0.00439	CcSEcCtD
Ranolazine—Visual impairment—Ifosfamide—germ cell cancer	0.00386	0.00439	CcSEcCtD
Ranolazine—Renal failure—Cisplatin—germ cell cancer	0.00378	0.0043	CcSEcCtD
Ranolazine—Anorexia—Vinblastine—germ cell cancer	0.00376	0.00427	CcSEcCtD
Ranolazine—Pancytopenia—Etoposide—germ cell cancer	0.00375	0.00427	CcSEcCtD
Ranolazine—Eye disorder—Ifosfamide—germ cell cancer	0.00374	0.00426	CcSEcCtD
Ranolazine—Tinnitus—Ifosfamide—germ cell cancer	0.00373	0.00425	CcSEcCtD
Ranolazine—Cardiac disorder—Ifosfamide—germ cell cancer	0.00372	0.00423	CcSEcCtD
Ranolazine—Leukopenia—Bleomycin—germ cell cancer	0.00365	0.00415	CcSEcCtD
Ranolazine—Depressed level of consciousness—Methotrexate—germ cell cancer	0.00364	0.00414	CcSEcCtD
Ranolazine—Angiopathy—Ifosfamide—germ cell cancer	0.00363	0.00413	CcSEcCtD
Ranolazine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00361	0.0041	CcSEcCtD
Ranolazine—Arrhythmia—Ifosfamide—germ cell cancer	0.00358	0.00407	CcSEcCtD
Ranolazine—Cough—Bleomycin—germ cell cancer	0.00356	0.00405	CcSEcCtD
Ranolazine—Paraesthesia—Vinblastine—germ cell cancer	0.00354	0.00402	CcSEcCtD
Ranolazine—Bradycardia—Cisplatin—germ cell cancer	0.00352	0.004	CcSEcCtD
Ranolazine—Mental disorder—Ifosfamide—germ cell cancer	0.00351	0.00399	CcSEcCtD
Ranolazine—Malnutrition—Ifosfamide—germ cell cancer	0.00349	0.00396	CcSEcCtD
Ranolazine—Renal failure—Etoposide—germ cell cancer	0.00346	0.00394	CcSEcCtD
Ranolazine—Decreased appetite—Vinblastine—germ cell cancer	0.00343	0.0039	CcSEcCtD
Ranolazine—Urinary tract disorder—Cisplatin—germ cell cancer	0.00341	0.00388	CcSEcCtD
Ranolazine—Leukopenia—Dactinomycin—germ cell cancer	0.00341	0.00387	CcSEcCtD
Ranolazine—Connective tissue disorder—Cisplatin—germ cell cancer	0.00339	0.00386	CcSEcCtD
Ranolazine—Urethral disorder—Cisplatin—germ cell cancer	0.00338	0.00385	CcSEcCtD
Ranolazine—Constipation—Vinblastine—germ cell cancer	0.00337	0.00383	CcSEcCtD
Ranolazine—Confusional state—Bleomycin—germ cell cancer	0.00336	0.00382	CcSEcCtD
Ranolazine—Visual impairment—Cisplatin—germ cell cancer	0.00333	0.00378	CcSEcCtD
Ranolazine—Vision blurred—Ifosfamide—germ cell cancer	0.00329	0.00374	CcSEcCtD
Ranolazine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00326	0.00371	CcSEcCtD
Ranolazine—Feeling abnormal—Vinblastine—germ cell cancer	0.00325	0.00369	CcSEcCtD
Ranolazine—Eye disorder—Cisplatin—germ cell cancer	0.00323	0.00367	CcSEcCtD
Ranolazine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00322	0.00366	CcSEcCtD
Ranolazine—Tinnitus—Cisplatin—germ cell cancer	0.00322	0.00366	CcSEcCtD
Ranolazine—Cardiac disorder—Cisplatin—germ cell cancer	0.0032	0.00364	CcSEcCtD
Ranolazine—Angioedema—Ifosfamide—germ cell cancer	0.00319	0.00362	CcSEcCtD
Ranolazine—Anorexia—Bleomycin—germ cell cancer	0.00317	0.00361	CcSEcCtD
Ranolazine—Hypoaesthesia—Etoposide—germ cell cancer	0.00315	0.00358	CcSEcCtD
Ranolazine—Vertigo—Ifosfamide—germ cell cancer	0.00313	0.00356	CcSEcCtD
Ranolazine—Urinary tract disorder—Etoposide—germ cell cancer	0.00312	0.00355	CcSEcCtD
Ranolazine—Leukopenia—Ifosfamide—germ cell cancer	0.00312	0.00355	CcSEcCtD
Ranolazine—Abdominal pain—Vinblastine—germ cell cancer	0.00312	0.00354	CcSEcCtD
Ranolazine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00311	0.00354	CcSEcCtD
Ranolazine—Hypotension—Bleomycin—germ cell cancer	0.00311	0.00354	CcSEcCtD
Ranolazine—Urethral disorder—Etoposide—germ cell cancer	0.0031	0.00353	CcSEcCtD
Ranolazine—Arrhythmia—Cisplatin—germ cell cancer	0.00308	0.00351	CcSEcCtD
Ranolazine—Palpitations—Ifosfamide—germ cell cancer	0.00308	0.0035	CcSEcCtD
Ranolazine—Cough—Ifosfamide—germ cell cancer	0.00304	0.00346	CcSEcCtD
Ranolazine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00304	0.00346	CcSEcCtD
Ranolazine—Malnutrition—Cisplatin—germ cell cancer	0.00301	0.00342	CcSEcCtD
Ranolazine—Paraesthesia—Bleomycin—germ cell cancer	0.00299	0.0034	CcSEcCtD
Ranolazine—Dyspnoea—Bleomycin—germ cell cancer	0.00297	0.00337	CcSEcCtD
Ranolazine—Renal failure acute—Methotrexate—germ cell cancer	0.00297	0.00337	CcSEcCtD
Ranolazine—Flatulence—Cisplatin—germ cell cancer	0.00296	0.00337	CcSEcCtD
Ranolazine—Anorexia—Dactinomycin—germ cell cancer	0.00296	0.00337	CcSEcCtD
Ranolazine—Eye disorder—Etoposide—germ cell cancer	0.00296	0.00336	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00295	0.00335	CcSEcCtD
Ranolazine—Cardiac disorder—Etoposide—germ cell cancer	0.00294	0.00334	CcSEcCtD
Ranolazine—Decreased appetite—Bleomycin—germ cell cancer	0.00289	0.00329	CcSEcCtD
Ranolazine—Visual disturbance—Methotrexate—germ cell cancer	0.00289	0.00329	CcSEcCtD
Ranolazine—Muscle spasms—Cisplatin—germ cell cancer	0.00289	0.00329	CcSEcCtD
Ranolazine—Angiopathy—Etoposide—germ cell cancer	0.00287	0.00326	CcSEcCtD
Ranolazine—Confusional state—Ifosfamide—germ cell cancer	0.00287	0.00326	CcSEcCtD
Ranolazine—Mediastinal disorder—Etoposide—germ cell cancer	0.00285	0.00324	CcSEcCtD
Ranolazine—Vision blurred—Cisplatin—germ cell cancer	0.00283	0.00322	CcSEcCtD
Ranolazine—Asthenia—Vinblastine—germ cell cancer	0.00283	0.00322	CcSEcCtD
Ranolazine—Tremor—Cisplatin—germ cell cancer	0.00282	0.0032	CcSEcCtD
Ranolazine—Lethargy—Methotrexate—germ cell cancer	0.00279	0.00318	CcSEcCtD
Ranolazine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00279	0.00317	CcSEcCtD
Ranolazine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00279	0.00317	CcSEcCtD
Ranolazine—Skin disorder—Ifosfamide—germ cell cancer	0.00276	0.00314	CcSEcCtD
Ranolazine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00275	0.00313	CcSEcCtD
Ranolazine—Feeling abnormal—Bleomycin—germ cell cancer	0.00274	0.00312	CcSEcCtD
Ranolazine—Anorexia—Ifosfamide—germ cell cancer	0.00271	0.00308	CcSEcCtD
Ranolazine—Decreased appetite—Dactinomycin—germ cell cancer	0.0027	0.00307	CcSEcCtD
Ranolazine—Leukopenia—Cisplatin—germ cell cancer	0.00269	0.00306	CcSEcCtD
Ranolazine—Fatigue—Dactinomycin—germ cell cancer	0.00268	0.00304	CcSEcCtD
Ranolazine—Hypotension—Ifosfamide—germ cell cancer	0.00266	0.00302	CcSEcCtD
Ranolazine—Muscle spasms—Etoposide—germ cell cancer	0.00265	0.00301	CcSEcCtD
Ranolazine—Urticaria—Bleomycin—germ cell cancer	0.00264	0.00301	CcSEcCtD
Ranolazine—Dizziness—Vinblastine—germ cell cancer	0.00261	0.00296	CcSEcCtD
Ranolazine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00256	0.00291	CcSEcCtD
Ranolazine—Paraesthesia—Ifosfamide—germ cell cancer	0.00256	0.0029	CcSEcCtD
Ranolazine—Anxiety—Cisplatin—germ cell cancer	0.00255	0.0029	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00254	0.00289	CcSEcCtD
Ranolazine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00254	0.00289	CcSEcCtD
Ranolazine—Dyspnoea—Ifosfamide—germ cell cancer	0.00254	0.00288	CcSEcCtD
Ranolazine—Somnolence—Ifosfamide—germ cell cancer	0.00253	0.00288	CcSEcCtD
Ranolazine—Vomiting—Vinblastine—germ cell cancer	0.00251	0.00285	CcSEcCtD
Ranolazine—Breast disorder—Methotrexate—germ cell cancer	0.00247	0.00281	CcSEcCtD
Ranolazine—Vertigo—Etoposide—germ cell cancer	0.00247	0.00281	CcSEcCtD
Ranolazine—Decreased appetite—Ifosfamide—germ cell cancer	0.00247	0.00281	CcSEcCtD
Ranolazine—Headache—Vinblastine—germ cell cancer	0.00247	0.00281	CcSEcCtD
Ranolazine—Leukopenia—Etoposide—germ cell cancer	0.00246	0.0028	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00246	0.00279	CcSEcCtD
Ranolazine—Abdominal pain—Dactinomycin—germ cell cancer	0.00245	0.00279	CcSEcCtD
Ranolazine—Fatigue—Ifosfamide—germ cell cancer	0.00245	0.00279	CcSEcCtD
Ranolazine—Constipation—Ifosfamide—germ cell cancer	0.00243	0.00277	CcSEcCtD
Ranolazine—Loss of consciousness—Etoposide—germ cell cancer	0.00242	0.00275	CcSEcCtD
Ranolazine—Nervous system disorder—Cisplatin—germ cell cancer	0.00241	0.00274	CcSEcCtD
Ranolazine—Cough—Etoposide—germ cell cancer	0.0024	0.00273	CcSEcCtD
Ranolazine—Thrombocytopenia—Cisplatin—germ cell cancer	0.0024	0.00273	CcSEcCtD
Ranolazine—Asthenia—Bleomycin—germ cell cancer	0.00239	0.00272	CcSEcCtD
Ranolazine—Skin disorder—Cisplatin—germ cell cancer	0.00238	0.00271	CcSEcCtD
Ranolazine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00237	0.0027	CcSEcCtD
Ranolazine—Pruritus—Bleomycin—germ cell cancer	0.00236	0.00268	CcSEcCtD
Ranolazine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00234	0.00267	CcSEcCtD
Ranolazine—Eosinophilia—Methotrexate—germ cell cancer	0.00234	0.00266	CcSEcCtD
Ranolazine—Nausea—Vinblastine—germ cell cancer	0.00234	0.00266	CcSEcCtD
Ranolazine—Anorexia—Cisplatin—germ cell cancer	0.00234	0.00266	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00233	0.00265	CcSEcCtD
Ranolazine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00233	0.00265	CcSEcCtD
Ranolazine—Pancreatitis—Methotrexate—germ cell cancer	0.00232	0.00264	CcSEcCtD
Ranolazine—Hypotension—Cisplatin—germ cell cancer	0.00229	0.00261	CcSEcCtD
Ranolazine—Abdominal discomfort—Methotrexate—germ cell cancer	0.00227	0.00258	CcSEcCtD
Ranolazine—Confusional state—Etoposide—germ cell cancer	0.00227	0.00258	CcSEcCtD
Ranolazine—Urticaria—Ifosfamide—germ cell cancer	0.00226	0.00257	CcSEcCtD
Ranolazine—Abdominal pain—Ifosfamide—germ cell cancer	0.00225	0.00256	CcSEcCtD
Ranolazine—Pancytopenia—Methotrexate—germ cell cancer	0.00225	0.00256	CcSEcCtD
Ranolazine—Asthenia—Dactinomycin—germ cell cancer	0.00223	0.00253	CcSEcCtD
Ranolazine—Dysuria—Methotrexate—germ cell cancer	0.00221	0.00252	CcSEcCtD
Ranolazine—Paraesthesia—Cisplatin—germ cell cancer	0.0022	0.0025	CcSEcCtD
Ranolazine—Thrombocytopenia—Etoposide—germ cell cancer	0.0022	0.0025	CcSEcCtD
Ranolazine—Dyspnoea—Cisplatin—germ cell cancer	0.00219	0.00249	CcSEcCtD
Ranolazine—Skin disorder—Etoposide—germ cell cancer	0.00218	0.00248	CcSEcCtD
Ranolazine—Erectile dysfunction—Methotrexate—germ cell cancer	0.00218	0.00248	CcSEcCtD
Ranolazine—Hyperhidrosis—Etoposide—germ cell cancer	0.00217	0.00247	CcSEcCtD
Ranolazine—Anorexia—Etoposide—germ cell cancer	0.00214	0.00244	CcSEcCtD
Ranolazine—Decreased appetite—Cisplatin—germ cell cancer	0.00213	0.00242	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00212	0.00241	CcSEcCtD
Ranolazine—Vomiting—Bleomycin—germ cell cancer	0.00212	0.00241	CcSEcCtD
Ranolazine—Hypotension—Etoposide—germ cell cancer	0.0021	0.00239	CcSEcCtD
Ranolazine—Rash—Bleomycin—germ cell cancer	0.0021	0.00239	CcSEcCtD
Ranolazine—Dermatitis—Bleomycin—germ cell cancer	0.0021	0.00238	CcSEcCtD
Ranolazine—Renal failure—Methotrexate—germ cell cancer	0.00207	0.00236	CcSEcCtD
Ranolazine—Asthenia—Ifosfamide—germ cell cancer	0.00204	0.00232	CcSEcCtD
Ranolazine—Feeling abnormal—Cisplatin—germ cell cancer	0.00202	0.0023	CcSEcCtD
Ranolazine—Paraesthesia—Etoposide—germ cell cancer	0.00202	0.00229	CcSEcCtD
Ranolazine—Pruritus—Ifosfamide—germ cell cancer	0.00201	0.00229	CcSEcCtD
Ranolazine—Haematuria—Methotrexate—germ cell cancer	0.00201	0.00229	CcSEcCtD
Ranolazine—Dyspnoea—Etoposide—germ cell cancer	0.002	0.00228	CcSEcCtD
Ranolazine—Somnolence—Etoposide—germ cell cancer	0.002	0.00227	CcSEcCtD
Ranolazine—Epistaxis—Methotrexate—germ cell cancer	0.00199	0.00226	CcSEcCtD
Ranolazine—Nausea—Bleomycin—germ cell cancer	0.00198	0.00225	CcSEcCtD
Ranolazine—Vomiting—Dactinomycin—germ cell cancer	0.00197	0.00224	CcSEcCtD
Ranolazine—Rash—Dactinomycin—germ cell cancer	0.00196	0.00223	CcSEcCtD
Ranolazine—Decreased appetite—Etoposide—germ cell cancer	0.00195	0.00222	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00194	0.00221	CcSEcCtD
Ranolazine—Fatigue—Etoposide—germ cell cancer	0.00194	0.0022	CcSEcCtD
Ranolazine—Constipation—Etoposide—germ cell cancer	0.00192	0.00218	CcSEcCtD
Ranolazine—Dizziness—Ifosfamide—germ cell cancer	0.00188	0.00214	CcSEcCtD
Ranolazine—Urinary tract disorder—Methotrexate—germ cell cancer	0.00187	0.00213	CcSEcCtD
Ranolazine—Urethral disorder—Methotrexate—germ cell cancer	0.00186	0.00211	CcSEcCtD
Ranolazine—Feeling abnormal—Etoposide—germ cell cancer	0.00185	0.00211	CcSEcCtD
Ranolazine—Nausea—Dactinomycin—germ cell cancer	0.00184	0.0021	CcSEcCtD
Ranolazine—Gastrointestinal pain—Etoposide—germ cell cancer	0.00184	0.00209	CcSEcCtD
Ranolazine—Visual impairment—Methotrexate—germ cell cancer	0.00183	0.00208	CcSEcCtD
Ranolazine—Vomiting—Ifosfamide—germ cell cancer	0.00181	0.00206	CcSEcCtD
Ranolazine—Rash—Ifosfamide—germ cell cancer	0.00179	0.00204	CcSEcCtD
Ranolazine—Dermatitis—Ifosfamide—germ cell cancer	0.00179	0.00204	CcSEcCtD
Ranolazine—Urticaria—Etoposide—germ cell cancer	0.00179	0.00203	CcSEcCtD
Ranolazine—Abdominal pain—Etoposide—germ cell cancer	0.00178	0.00202	CcSEcCtD
Ranolazine—Eye disorder—Methotrexate—germ cell cancer	0.00177	0.00201	CcSEcCtD
Ranolazine—Tinnitus—Methotrexate—germ cell cancer	0.00177	0.00201	CcSEcCtD
Ranolazine—Asthenia—Cisplatin—germ cell cancer	0.00176	0.002	CcSEcCtD
Ranolazine—Cardiac disorder—Methotrexate—germ cell cancer	0.00176	0.002	CcSEcCtD
Ranolazine—Angiopathy—Methotrexate—germ cell cancer	0.00172	0.00195	CcSEcCtD
Ranolazine—Mediastinal disorder—Methotrexate—germ cell cancer	0.00171	0.00194	CcSEcCtD
Ranolazine—Nausea—Ifosfamide—germ cell cancer	0.00169	0.00192	CcSEcCtD
Ranolazine—Mental disorder—Methotrexate—germ cell cancer	0.00166	0.00189	CcSEcCtD
Ranolazine—Malnutrition—Methotrexate—germ cell cancer	0.00165	0.00188	CcSEcCtD
Ranolazine—Asthenia—Etoposide—germ cell cancer	0.00161	0.00183	CcSEcCtD
Ranolazine—Pruritus—Etoposide—germ cell cancer	0.00159	0.00181	CcSEcCtD
Ranolazine—Vomiting—Cisplatin—germ cell cancer	0.00156	0.00177	CcSEcCtD
Ranolazine—Vision blurred—Methotrexate—germ cell cancer	0.00155	0.00177	CcSEcCtD
Ranolazine—Rash—Cisplatin—germ cell cancer	0.00155	0.00176	CcSEcCtD
Ranolazine—Dermatitis—Cisplatin—germ cell cancer	0.00155	0.00176	CcSEcCtD
Ranolazine—Dizziness—Etoposide—germ cell cancer	0.00149	0.00169	CcSEcCtD
Ranolazine—Vertigo—Methotrexate—germ cell cancer	0.00148	0.00168	CcSEcCtD
Ranolazine—Leukopenia—Methotrexate—germ cell cancer	0.00148	0.00168	CcSEcCtD
Ranolazine—Nausea—Cisplatin—germ cell cancer	0.00146	0.00166	CcSEcCtD
Ranolazine—Cough—Methotrexate—germ cell cancer	0.00144	0.00164	CcSEcCtD
Ranolazine—Vomiting—Etoposide—germ cell cancer	0.00143	0.00162	CcSEcCtD
Ranolazine—Rash—Etoposide—germ cell cancer	0.00142	0.00161	CcSEcCtD
Ranolazine—Dermatitis—Etoposide—germ cell cancer	0.00142	0.00161	CcSEcCtD
Ranolazine—Headache—Etoposide—germ cell cancer	0.00141	0.0016	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00139	0.00159	CcSEcCtD
Ranolazine—Confusional state—Methotrexate—germ cell cancer	0.00136	0.00154	CcSEcCtD
Ranolazine—Nausea—Etoposide—germ cell cancer	0.00133	0.00152	CcSEcCtD
Ranolazine—Nervous system disorder—Methotrexate—germ cell cancer	0.00132	0.0015	CcSEcCtD
Ranolazine—Thrombocytopenia—Methotrexate—germ cell cancer	0.00132	0.0015	CcSEcCtD
Ranolazine—Skin disorder—Methotrexate—germ cell cancer	0.00131	0.00149	CcSEcCtD
Ranolazine—Hyperhidrosis—Methotrexate—germ cell cancer	0.0013	0.00148	CcSEcCtD
Ranolazine—Anorexia—Methotrexate—germ cell cancer	0.00128	0.00146	CcSEcCtD
Ranolazine—Hypotension—Methotrexate—germ cell cancer	0.00126	0.00143	CcSEcCtD
Ranolazine—Insomnia—Methotrexate—germ cell cancer	0.00122	0.00138	CcSEcCtD
Ranolazine—Paraesthesia—Methotrexate—germ cell cancer	0.00121	0.00137	CcSEcCtD
Ranolazine—Dyspnoea—Methotrexate—germ cell cancer	0.0012	0.00136	CcSEcCtD
Ranolazine—Somnolence—Methotrexate—germ cell cancer	0.0012	0.00136	CcSEcCtD
Ranolazine—Dyspepsia—Methotrexate—germ cell cancer	0.00118	0.00135	CcSEcCtD
Ranolazine—Decreased appetite—Methotrexate—germ cell cancer	0.00117	0.00133	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00116	0.00132	CcSEcCtD
Ranolazine—Fatigue—Methotrexate—germ cell cancer	0.00116	0.00132	CcSEcCtD
Ranolazine—Feeling abnormal—Methotrexate—germ cell cancer	0.00111	0.00126	CcSEcCtD
Ranolazine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.0011	0.00125	CcSEcCtD
Ranolazine—Urticaria—Methotrexate—germ cell cancer	0.00107	0.00122	CcSEcCtD
Ranolazine—Abdominal pain—Methotrexate—germ cell cancer	0.00106	0.00121	CcSEcCtD
Ranolazine—Asthenia—Methotrexate—germ cell cancer	0.000966	0.0011	CcSEcCtD
Ranolazine—Pruritus—Methotrexate—germ cell cancer	0.000952	0.00108	CcSEcCtD
Ranolazine—Dizziness—Methotrexate—germ cell cancer	0.00089	0.00101	CcSEcCtD
Ranolazine—Vomiting—Methotrexate—germ cell cancer	0.000856	0.000973	CcSEcCtD
Ranolazine—Rash—Methotrexate—germ cell cancer	0.000849	0.000965	CcSEcCtD
Ranolazine—Dermatitis—Methotrexate—germ cell cancer	0.000848	0.000964	CcSEcCtD
Ranolazine—Headache—Methotrexate—germ cell cancer	0.000843	0.000959	CcSEcCtD
Ranolazine—Nausea—Methotrexate—germ cell cancer	0.0008	0.000909	CcSEcCtD
